Sentences with phrase «program sharing revenue»

Amazon spokeswoman Angie Newman said the company had previously removed Jihad Watch and three other sites identified by ProPublica from its program sharing revenue for book sales, which is called Amazon Associates.

Not exact matches

The project expands Airbnb's «Friendly Buildings Program» which shares revenue generated from home sharing between hosts and landlords.

Specialty food retailer Whole Foods Market tumbled 6 percent after it missed revenue expectations, boosted its dividend and announced a $ 1 billion share repurchase program.

Then, in 2009, YouTube started a partner program which enabled the most popular content creators — like Southern — to begin to earn money by sharing in the revenue from their ads.

The company, which has annual revenue of $ 6 million, is also bidding on upcoming bike - sharing programs in San Francisco; Portland, Oregon; Vancouver, British Columbia; and Copenhagen.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tPrograms (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Between 1983 - 84 and 1994 - 95, program spending under Mulroney fell from 18.4 % of GDP to 15.7 %, while the revenue share actually rose from 15.6 % to 16.6 %.

The one thing many content marketers don't know to this very day is the longer the pages they publish and the more meaningful relationships they build, the faster they improve their natural search engine rankings, the faster they improve their advertising revenue from promoting affiliate programs on blogs and websites, the more likes they get from people on Facebook, Twitter, LinkedIn, and Pinterest, and free advertising from people on social networks by way of sharing links to their published Evergreen pages on social networking profiles.

As the Update says program spending is falling as a share of GDP, and revenues as a share of GDP are at their lowest level in fifty years.

All of this in a backdrop of CVS being highly acquisitive, continuing to deliver robust earnings growth, revenue growth, growing dividends and has an aggressive share buyback program in place.

As well as missing revenue forecasts, Alibaba announced a $ 4 billion share repurchase program over two years, which it said was primarily aimed at offsetting the impact of the company's share - based compensation programs and other factors that could dilute the share price.

PNC Equipment Finance's Vendor Program Business Development team customize sales finance programs for global manufacturers, distributors, software and service providers that assist in generating incremental revenue that enhance margins and improve market share.

The Athletics, on the other hand, accused of pocketing revenue sharing money in 2016 and thus beginning to be phased out of the program under the CBA, had a quiet offseason.

When schools offer both a school meals program and competitive foods, the federal government does not need to underwrite all of the operating costs of the entire program; it is reasonable to expect the revenue generated by competitive foods to cover a share of production, service, and overhead that can reasonably be attributed to providing those foods.

The four - part plan supported by FPI: implement a statewide solution to CFE; increase state's share of Medicaid and base counties» shares on ability to pay; restore commitment to revenue sharing; and eliminate the significant disparities in the STAR program.

In recent days that agenda has focused more on Upstate as Cuomo rolled out details for expanded gambling, then two revenue - sharing agreements with Native American - run casinos, and now a tax program that would favor communities with SUNY schools that are primarily outside of New York City.

«These local sales tax revenues enable counties and other local governments that also receive a share of these revenues, to pay for state mandated programs and provide critical local services that would disappear,» Acquario stated.

He is imposing more cuts in local government services by tying the state tax relief programs to municipal compliance with the 2 percent property tax cap while simultaneously freezing revenue - sharing aid to municipalities at 75 percent below its 1980s level,» Hawkins said.

Voters should remember that New York City was singled out by Albany and eliminated from the revenue sharing program, while other localities took no more than a three percent cut.»

Oneida County is using some its share in revenue from the Turning Stone casino to fund arts and science programs.

In addition, Fasano said that Malloy was «withholding funding mandated by the Municipal Revenue Sharing Program without legislative approval.»

Hawkins said he would use the over $ 25 billion in additional revenues to restore revenue sharing to its original standard of 8 % of state revenues, which is now at less than 1 %, and to pay for his Green New Deal program.

Third, the amount is misleading given the County local share of that program can come from many local revenue sources, including Sales Tax, Residential Energy Tax, Hotel / Motel Occupancy Tax, County Mortgage Tax as well as Real Property Taxes.

Progressive Taxes and Revenue Sharing to end the fiscal crises of our local governments and schools, Tuition - Free Public Colleges and Universities, Single Payer Health Care, $ 15 Minimum Wage, Public Banking, Union Co-ops, a Ban on Fracking, a Climate Acton Program scaled up to meet the crisis, and more.

Entering its tenth year, Pioneer Hi - Bred's «Corn for Student Lunch Program,» involving 14,000 people, has estimated revenues exceeding US$ 330,000, which is shared among all 43 participating schools.

Userplane offers free, ad - supported Userplane Webmessenger 2 packages and is planning to launch an advertising revenue - sharing program in the next 60 days.

Userplane serves 1 billion ads per month and is planning to roll out an advertising revenue - sharing program later this quarter.

BUSINESS WIRE — Jan 16 — Userplane, a subsidiary of AOL, today announced that PlentyofFish, the world's top free dating site, has joined Userplane's new ad revenue - sharing program.

«Userplane Launches Ad Revenue - Sharing Program; Dating Site PlentyofFish Hauls in «Significant» Revenue Main IceBreaker Allows Cell Phone Users to Meet Anytime, Anywhere»

Thank to placing our affiliate program on romance - net catalogue more than 50 webmasters were able to start using our AdSense Revenue Share program.

These dollars were split into a few large categories: supersized spending for the Title I and special - education formula programs, and a «state stabilization fund» that essentially amounted to revenue sharing.

The individuals who attend our higher education programs share concerns about how to generate new and different sources of revenue beyond traditional state funding.

The lion's share of these ARRA education dollars was appropriated through the new $ 50 billion State Fiscal Stabilization Fund (SFSF), a population - based program created to expeditiously replenish education budgets decimated by declining tax revenue.

It also issued its full year 2018 and First Quarter guidance: «GEO expects full - year 2018 total revenue to be approximately $ 2.3 billion,» which «does not assume the reactivation of GEO's approximately 7,000 idle and underutilized beds or any share repurchases under GEO's $ 200 million share repurchase program.»

With the local share of the total cost of educating students rising to nearly 60 % in 2014 - 15, even with the continued reductions in staff and academic programs, additional local revenue will be needed in many districts to balance budgets.

SEATTLE, Jan 20, 2010 (BUSINESS WIRE)-- Amazon.com (NASDAQ: AMZN) today announced details of a new program that will enable authors and publishers who use the Kindle Digital Text Platform (DTP) to earn a larger share of revenue from each Kindle book they sell.

KDP Select, a lending program that encourages self - published authors and publishers to make their work available exclusively in the Kindle Store for 90 - day periods in exchange for a potential revenue share, is part of that effort.

Once you have amassed over a few thousand followers Twitch will cut you in for a revenue share program, in addition to being able to accept donations immediately.

Authors wishing to participate in some other revenue - sharing programs, such as Amazon's Kindle Unlimited program, could only do so if Kindle was the only platform they distributed to.

The revenue share program is poised to give the creators 20 % of everything sold through all the various platforms.

Right off the heels of announcing an expansion of its Kindle Digital Text Platform to authors and publishers around the world, Amazon has announced that it will soon introduce a new 70 percent royalty option in the program that will allow them to to earn a larger share of revenue from each Kindle book they sell.

Second, when the borrowers discover that they didn't finish with Amazon's 14 - day lending window, offer a link to buy the e-book and share a portion of the resulting revenue through Amazon's affiliate program.

Write articles related to topics that interest you and publish them to sites that offer revenue sharing programs, such as Associated Content or eHow (see Resources below).

By participating in the KDP Select program, authors are able to participate in Amazon's revenue sharing program by agreeing to allow their Kindle books to be loaned out to Amazon Prime members.

Amendments of various tax acts to permit the sharing of taxpayer information within Canada Revenue Agency to facilitate the collection of non-tax debt under certain federal and provincial programs

Colleges that participate in revenue sharing agreements with lenders (e.g., School as Lender schools and some private student loan programs) should ensure that the loans are competitive with the best loans available from other lenders.

Reversionary working interest: In oil and gas programs, a sharing arrangement whereby the general partner does not share in revenues until the limited partners have recouped their initial investment.

Thanks to a big share buyback program the firm still sports a modest amount of revenue - per - share growth over the last three years.

Odysseys Surf School offers a revenue - sharing affiliate program.

Delta's new revenue - based frequent flyer program has only shared details of how miles will be earned — based on the money you spend, rather than the miles you fly (time spent with an airline on their planes)-- and not how miles will be spent.